ESR and CRP in Amyloidosis
In amyloidosis, ESR is typically elevated while CRP may be normal or only mildly elevated, creating a characteristic dissociation between these two inflammatory markers that can be a diagnostic clue.
Characteristic Pattern of Inflammatory Markers
ESR Behavior in Amyloidosis
- ESR is usually elevated in amyloidosis, particularly in AA (secondary) amyloidosis where it reflects the underlying chronic inflammatory condition 1, 2, 3
- In AA amyloidosis secondary to familial Mediterranean fever (FMF), baseline ESR values averaged 48.7 ± 31.0 mm/h before treatment 1
- Even during attack-free periods in FMF patients with amyloidosis, ESR remains significantly elevated compared to those without amyloidosis, indicating persistent subclinical inflammation 2
- The elevation of ESR in amyloidosis is related to increased fibrinogen and other acute phase proteins that accumulate as part of the disease process 4
CRP Behavior in Amyloidosis
- CRP may be normal or only mildly elevated in AL (light chain) amyloidosis, despite significant disease burden 5
- In AA amyloidosis, CRP is typically elevated, reflecting the underlying inflammatory condition, with baseline values averaging 18.1 ± 19.5 mg/L in FMF-associated cases 1
- CRP levels are significantly higher in FMF patients with amyloidosis compared to those without amyloidosis during attack-free periods 2
- In AA amyloidosis, both ESR and CRP remain elevated even with anti-IL-1 therapy, though they decrease significantly (CRP from 18.1 to 5.8 mg/L and ESR from 48.7 to 28.7 mm/h) 1
Critical Diagnostic Pitfall
Normal ESR Does NOT Exclude Amyloidosis
- A normal ESR does not exclude the diagnosis of amyloidosis, particularly AL amyloidosis 5
- A case report documented a 65-year-old woman with AL amyloidosis secondary to multiple myeloma who presented with normal ESR and normal urinalysis initially 5
- When clinical features suggest amyloidosis (such as stiffness, recurrent carpal tunnel syndrome, or dysphagia), further workup including free light chain analysis should be performed even with normal ESR 5
Clinical Context by Amyloidosis Type
AA (Secondary) Amyloidosis
- Both ESR and CRP are typically elevated, reflecting the underlying chronic inflammatory disease (such as FMF, rheumatoid arthritis, or chronic infections) 1, 2, 3
- These markers remain elevated even during clinically quiescent periods, indicating ongoing subclinical inflammation 2
- Treatment with IL-1 inhibitors significantly reduces but does not fully normalize these markers compared to healthy controls 2, 3
AL (Light Chain) Amyloidosis
- ESR may be normal or elevated, and CRP is often normal or only mildly elevated 5
- This dissociation between clinical severity and inflammatory markers is characteristic and can delay diagnosis 5
- The lack of elevated acute phase reactants reflects the non-inflammatory nature of plasma cell dyscrasia-related amyloid deposition 5
Monitoring Treatment Response
- ESR and CRP are useful for monitoring treatment response in AA amyloidosis 1, 3
- Following IL-1 inhibitor therapy in FMF-associated AA amyloidosis, significant reductions occur: ESR decreases by approximately 40% and CRP normalizes in about 70% of patients 1, 3
- CRP normalizes more rapidly than ESR during treatment, making it more useful for assessing acute treatment response 4
- ESR has a longer half-life (reflecting fibrinogen levels) and is better suited for monitoring chronic inflammatory conditions over time 4
Practical Algorithm for Interpretation
When evaluating inflammatory markers in suspected amyloidosis:
If ESR is elevated with normal or mildly elevated CRP, consider AL amyloidosis and check serum free light chains and immunofixation 5
If both ESR and CRP are significantly elevated, consider AA amyloidosis and investigate underlying chronic inflammatory conditions 1, 2
If ESR and CRP are both normal but clinical suspicion remains high (carpal tunnel syndrome, nephrotic syndrome, restrictive cardiomyopathy, peripheral neuropathy), proceed with tissue biopsy and free light chain analysis regardless 5
In established AA amyloidosis on treatment, monitor both markers monthly, expecting CRP to normalize faster than ESR 1, 4